Mark Markowski

26PUBLICATIONS
121CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Natural language processingPeripheral nervous systemPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 30, 2026
Immunometabolic effects of oral testosterone for castration-resistant prostate cancer in the ACROBAT trial.

|May 01, 2026
HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer.

|Mar 27, 2026
Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on 18F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest Cohort.

Md Zobaer Islam, Timothy G Perk, Amy Weisman

|Feb 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.

Madelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh

|Jan 10, 2026
A Star-PEGylation Strategy to Improve Testosterone Pharmacokinetics.

Chae Bin Lee, Lukáš Tenora, Ruoning Zhang

|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

Pageof 5

Frequent Collaborators

9 joint publications

Emmanuel S Antonarakis

9 joint publications

Channing J Paller

9 joint publications

Samuel R Denmeade

8 joint publications

Catherine H Marshall